C. Hearings and Witnesses

Thursday, 3 September 2020 - Canberra
Department of Health
Ms Penny Shakespeare, Deputy Secretary, Health Resourcing
Adjunct Prof John Skerritt, Deputy Secretary, Health Products Regulation
Dr Jane Cook, Fist Assistant Secretary, Medicines Regulation
Ms Tracey Duffy, First Assistant Secretary, Medical Devices and Product Quality
Ms Adriana Platona, First Assistant Secretary, Technology Assessment and Access
Dr Allyson Essex, Assistant Secretary, Health Economics and Modelling Branch
Dr Masha Somi, Assistant Secretary, Health and Medical Research Office
Friday, 5 February 2021 - Canberra
Department of Health
Prof Brendan Murphy, Secretary
Adj Prof John Skerritt, Deputy Secretary, Health Products Regulation
Dr Jane Cook, First Assistant Secretary, Health Products Regulation, Medicines Regulation
Dr Grant Pegg, Assistant Secretary, Prescription Medicines Authorisation Branch, Medicines Regulation Division
Ms Hope Peisley, Assistant Secretary, COVID-19 Vaccine Taskforce
Australian Technical Advisory Group on Immunisation (ATAGI)
Prof Allen Cheng, Co-Chair
Thursday, 11 March 2021 - Sydney
Rare Voices Australia
Prof Adam Jaffe, Member of Scientific and Medical Advisory Committee
Mrs Nicole Millis, Chief Executive Officer
Dr Kaustuv Bhattacharya, Scientific Advisor
Medical Technology Association of Australia
Mr Ian Burgess, Chief Executive Officer
Mr George Faithfull, Advisory, Vice-Chair Regulatory Affairs Strategic Committee
Mr Paul Dale, Policy Director
Dr Merrilyn Clancy, Senior Policy Officer
Bowel Cancer of Australia
Mrs Joni Thomes, Communications & Strategic Communications
JDRF Australia
Mr Mike Wilson, Chief Executive Officer
Allergy & Anaphylaxis Australia
Ms Maria Said, Chief Executive Officer
Fabry Australia
Mrs Sheridan Campbell, Chair
Migraine and Headache Australia
Mr Carl Cincinnato, Lead
Australian Pompe Association
Mr Raymond Saich, President
Save Our Sons Duchenne Foundation
Mr Lance Dale, Advocacy Officer
Cystic Fibrosis Australia
Mrs Annette Burke, Chief Executive Officer
Alpha-1 Organisation Australia Inc.
Dr Gaynor Heading, President
Macquarie University Centre for the Health Economy
Prof Martin Hoyle, Professor of Health Innovation and Evaluation
Australasian Association of Nuclear Medicine Specialists
Dr Geoff Schembri, President
Australian and New Zealand Society of Nuclear Medicine
Prof Dale Bailey
Australian Nuclear Science and Technology Organisation
Mr Shaun Jenkinson, Chief Executive Officer (Acting)
Dr Susanne O'Malley, Private capacity
Mr Michael Smith, Private capacity
Shawview Consulting
Dr Brendan Shaw, Principal
Medical Oncology Group of Australia
Dr Deme Karikios, Deputy Chair
Friday, 12 March 2021 - Sydney
Merck Healthcare Pty Ltd
Ms Leah Goodman, Managing Director Australia and New Zealand
Biogen Australia and New Zealand
Dr Kylie Bromley, Managing Director
Pfizer Australia
Ms Louise Graham, Director, Head of Market Access
Ms Anne Harris, Country Manager
Merck Sharp & Dohme Australia
Mr Michael Azrak, Managing Director
Amgen Australia
Mr Ian Noble, Director, Value, Access & Policy
Mr Chris Stemple, Vice President and General Manager, Australia and New Zealand
Novartis Australia and New Zealand
Mr Richard Tew, Country President and Pharma Country Head
Sydney Children's Hospital Network and Children's Medical Research Institute
Prof Ian Alexander, Head, Gene Therapy Research Unit
Kids Research, Sydney Children’s Hospital Network
Dr Wendy Gold, Chair Gene Therapy Advisory Steering Group & Head of Molecular Neurobiology Research Group
BXTAccelyon Limited
Mrs Nicola Leavold, Commercial Director
Medtronic Australasia
Ms Liz Carnabuci, Vice President & Managing Director, ANZ
Biotronik Australia Pty Ltd
Ms Jan Ewert, Managing Director
Edwards Lifesciences Pty Ltd
Mr Pat Williams, Managing Director
Stryker South Pacific
Mr Maurice Ben-Mayor, President
Maridulu Budyari Gumal, Sydney Partnership for Health, Education, Research and Enterprise (SPHERE)
Dr Peter Spencer, Medtech Innovation Advisor and HealthHatchery Co-Founder
Rowena Tucker, Interim Executive Director
Friday, 26 March 2021 - Canberra
Medicines Australia
Ms Elizabeth de Somer, Chief Executive Officer
Dr Anna Lavelle, Chair
Mr Jamie Snashall, Head of Government Relations
Mr Mark Stewart, Manager Research and Data
Pharmacy Guild of Australia
Mr Philip Chindamo, Group Executive Health Economics
Mr Chris Flood, Senior Pharmacist and National Manager PBS Operations & Strategy
MND Australia
Mr David Ali, Chief Executive Officer
Dr Gethin Thomas, Executive Director Research
Ms Carol Bennett, Chief Executive Officer
Dr Bruce Baer Arnold, Private capacity
Thursday, 22 April 2021 - Melbourne
Australian Patient Advocacy Alliance
Ms Deidre MacKechnie, Executive Officer
Myeloma and Related Diseases Registry
Prof Andrew Spencer, Chief Investigator
Prader-Willi Research Foundation Australia
Dr Elizabeth Patterson
Psychedelic Research In Science and Medicine Inc.
Ms Stephanie Tzanetis, Member
GUARD Collaborative Australia
Ms Monica Ferrie, Founder
SCN2A Australia
Ms Kris Pierce, Founder
Metabolic Dietary Disorders Association
Ms Louise Healy, Vice President
Specialised Therapeutics Australia
Mr Carlo Montagner, Chief Executive Officer
ViiV Healthcare
Mr Michael Graham, Country Manager
CSL Behring
Ms Loretta Croker, General Manager
Australian Antimicrobial Resistance Network
Dr Daniel Grant, Managing Director and Chief Executive Officer and Co-Chair
Dr Mark Hodge, Chief Executive Officer
Association of Australian Medical Research Institutes (AAMRI)
Dr Jacqui Waterkeyn, Member
Ipsen Pty Ltd
Mr Peter Koetsier, Head of Asia Pacific (excluding China) & General Manager of Australia and New Zealand
Mr Jason Aldworth, Chairman
Friday, 23 April 2021 - Melbourne
UCB Australia
Ms Selina Clifford, Head of Neurology & Country Lead
Gilead Sciences
Ms Jaime McCoy, General Manager
Bristol Myers Squibb Australia
Mr Neil MacGregor, Managing Director
Monash Institute of Medical Engineering
Prof John Forsythe, Co-Director
Prof Helena Teede, Co-Director
Research Australia
Mr Greg Mullins, Head of Policy
Melbourne Academic Centre for Health
Prof Andrew Davidson, Medical Director, Melbourne Children's Trials Centre and Chair Clinical Trials Committee
University of Melbourne
Dr Heather St John, Director, Research and Enterprise Development, Research, Innovation and Commercialisation
Melbourne's Children's Campus
Prof Andrew Davidson, Medical Director, Melbourne Children's Trials Centre
White Coats Foundation
Mrs Christine Zahren, Director
Victorian Comprehensive Cancer Centre
Prof Grant McArthur, Executive Director
Melanoma & Skin Cancer Advocacy Network
Ms Tamara Dawson, Director
Ovarian Cancer Australia
Ms Jane Hill, Chief Executive
NeuroEndocrine Cancer Australia
Ms Simone Leyden, Chief Executive Officer and Co-Founder
Leukaemia Foundation
Mr Tim Murphy, General Manager, Blood Cancer Partnerships
Blood Cancer Taskforce
Prof John Seymour, Co-Chair
Australasian Leukaemia and Lymphoma Group
Ms Delaine Smith, Chief Executive Officer
Haemophilia Foundation Australia
Ms Sharon Caris, Executive Director
Australian and New Zealand Children's Haematology/Oncology Group
Acting Prof Jordan Hansford, Director, CNS Group Chair
Friday, 7 May 2021 - Sydney
Alexion Pharmaceuticals Australasia
Ms Sara Trafford-Jones, Vice President - South Cluster Lead (Brazil, Colombia, Turkey); General Manager Australian/New Zealand/China
Kyowa Kirin Australia
Mr Simon Dawson, General Manager
BioMarin Pharmaceutical Australia Pty Ltd
Dr Kathryn Evans, Area Director, Australia and New Zealand
Recordati Rare Diseases Australia
Mr Anthony Shelton, General Manager
Takeda Pharmaceuticals Australia Pty Ltd
Mr Brad Edwards, General Manager, Australia and New Zealand
Ms Vanessa Xavier, Head of Market Access, Australia and New Zealand
Varian Medical Systems Australasia
Mrs Rebecca Cortiula, Senior Managing Director, Australasia
Amicus Therapeutics
Dr Simon McErlane, Medical Director, APAC
Myriad Genetics Pty Ltd
Ms Andrea Tesoriero, Associate Director, Asia Pacific
Roche Australia
Mr Stuart Knight, General Manager
Eli Lilly Australia
Mr Benjamin Basil, President and General Manager Australia, New Zealand and North Asia-Pacific
Novo Nordisk Oceania
Mr Jeppe Theisen, Vice President and General Manager
Bayer Australia and New Zealand
Mr Ashraf Al-Ouf, General Manager
Luminesce Alliance
Acting Professor Michelle Farrar, Clinician representative from the University of New South Wales, a partner in the Luminesce Alliance
Rare Cancers Australia
Mr Richard Vines, Chief Executive
Australasian Society of Clinical Immunology and Allergy
Professor Connie Katelaris AM, Chair, Drug Allergy Committee and ASCIA HAE, CSU and CRNP Working Parties
Ms Jill Smith, Chief Executive Officer
Dr Theresa Cole, President Elect and Co-Chair, Immunodeficiency Committee
Dr Melanie Wong, Co-Chair, Immunodeficiency Strategy
Professor Jo Douglass, Co-Chair, Immunodeficiency Strategy
Professor Michaela Lucas, President
Australia and New Zealand Legal and Regulatory Affairs Committee of the International Society of Cell and Gene Therapy
Dr Gabrielle O'Sullivan, Co-Chair
Australian Clinical Trials Alliance
Professor John Zalcberg OAM, Chair
The George Institute for Global Health
Professor Bruce Neal, Executive Director, Australia
The University of New South Wales
Professor Louisa Jorm, Professor, Faculty of Medicine and Director, Centre for Big Data Research in Health
Monday, 17 May 2021 - Brisbane
Patient Voice Initiative
Jessica Bean, Chair
Migraine Australia
Dr Raphaella Kathryn Crosby, Founder and Campaigns Director
Eczema Support Australia
Mrs Ruth Duggan, Project Team Member
XLH Australia Inc.
Mrs Naomi Elizabeth Ford, Vice President
Narcolepsy Australia
Mrs Melissa Jose, President
Ms Amanda Vernon, Private capacity
Sleep Disorders Australia and Hypersomnolence Australia
Mrs Michelle Chadwick, Chairperson
Foundation for Angelman Syndrome Therapeutics Australia
Mrs Meagan Cross, Chairperson
QIMR Berghofer
Professor Fabienne Mackay, Director and Chief Executive Officer
Results International Australia
Mr Mark Rice, Policy and Advocacy Manager
Dr Haitham Tuffaha, Private capacity
MedReleaf Australia
Mr Nathan Davis, Director - Head of Business Development
Mr Russell Harding, Executive Chairman and Chief Executive Officer
Mr Hugh Tait, Pharmacist
Ms Jeneth Boughen, Owner and General Manager
Tuesday, 18 May 2021 - Brisbane
ausEE Inc.
Mrs Sarah Gray, President and Founder
Myasthenia Alliance Australia
Mrs Susan White, Chairperson
ITP Australia
Mrs Danielle Boyle, Chief Executive Officer
Lymphoma Australia
Ms Sharon Winton, Chief Executive Officer
Australian Amyloidosis Network
Dr Peter Mollee, Executive Committee Member
Mrs Patricia Neely, Patient and Family Advocate and Member of the Australian Amyloidosis Network Management Team
Queensland Genomics Health Alliance Community Advisory Group
Dr Erin Evans, Chair
Queensland Genomics Health Alliance Community Advisory Group
Mr David Bunker, Executive Director
Ms Louise Healy, Member
Ms Michelle Burke, Chair
Ms Lorraine Chiroiu, Chief Executive Officer
Friday, 18 June 2021 - Canberra
National Aboriginal Community Controlled Health Organisation
Dr Dawn Casey, Deputy Chief Executive Director
Mr Mike Stephens, Director, Medicines Policy and Programs
Pathology Technology Australia
Dr John Melki, Member
Ms Susan Martland, Member
Mr Dominic De Souza, Member
Mr Dean Whiting, Chief Executive Officer
Department of Health
Adjunct Professor John Skerritt, Deputy Secretary, Health Products Regulation
Ms Tracey Duffy, First Assistant Secretary, Medical Devices and Product Quality, Health Products Regulation
Ms Trish Garrett, First Assistant Secretary, Cancer Hearing and Program Support
Ms Adriana Platona, First Assistant Secretary, Technology Assessment and Access
Ms Thea Connolly, Assistant Secretary, Office of Health, Technology Assessment Branch
Dr Megan Keaney, Principal Medical Adviser, Technology Assessment and Access
Thursday, 24 June 2021 - Canberra
Pharmaceutical Benefits Advisory Committee, Department of Health
Professor Andrew Wilson, Chair
Ms Jo Watson, Deputy Chair
Wednesday, 7 July 2021 - Canberra
United Kingdom National Institute for Health and Care Excellence
Mr Meindert Boysen, Deputy CEO and Director of The Centre for Health Technology Evaluation

 |  Contents  |